Announced Mon, 27 Jul · 17:28 IST
Senores Pharma Q1FY27 IPO fund report: Atlanta project delayed, reallocation proposed
Compliance View source PDF
SENORES · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
—1-day move
₹1397.90
prior close
₹1408.30
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-6.5-6.1-7.4-5.3——————————
Up moveDown movePending
AI summary
CARE Ratings monitoring report for Q1FY27 shows Rs 399.46 crore utilized out of Rs 500 crore IPO proceeds. Remaining Rs 100.54 crore sits in ICICI Bank fixed deposits at 5.85 percent. Major concern: ongoing delay in Atlanta sterile injections facility due to geopolitical issues. Company seeks shareholder approval to cut Atlanta allocation from Rs 107 crore to Rs 41.98 crore and reallocate Rs 65.02 crore to SPI for ANDA acquisitions, Apnar Vadodara expansion, and Havix OSD facility.
Likely market impact
IPO project delays and proposed reallocation may worry investors, though idle funds earn 5.85 percent interest in fixed deposits.